Cargando…

Therapeutic challenges in hepatitis C-infected injection drug using patients

Hepatitis C Viral (HCV) infection in the injection drug user (IDU) population is a major medical concern. Concurrent substance abuse, co-morbid mental health conditions, poor socioeconomic status and a complex treatment protocol that is often incompatible with the life styles of IDUs combine to acco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Curtis L, Mills, Edward J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1664558/ https://www.ncbi.nlm.nih.gov/pubmed/17096852 http://dx.doi.org/10.1186/1477-7517-3-31

Ejemplares similares

Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis
por: Druyts, Eric, et al.
Publicado: (2012)

Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections
por: Meshram, Rohan Janardhan, et al.
Publicado: (2022)

Challenging hepatitis C-infected liver transplant patients
por: Oliver, Madeleine, et al.
Publicado: (2016)

Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection
por: Druyts, Eric, et al.
Publicado: (2013)

Increased hepatitis C virus co-infection and injection drug use in HIV-infected fishermen in Myanmar
por: Ousley, Janet, et al.
Publicado: (2018)

The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa
por: Mahmud, Sarwat, et al.
Publicado: (2020)

Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis
por: Cooper, Curtis L, et al.
Publicado: (2012)

Urgent action to fight hepatitis C in people who inject drugs in Europe
por: Dillon, John F., et al.
Publicado: (2016)

Drug-based therapeutic strategies for COVID-19-infected patients and their challenges
por: Zarkesh, Khatereh, et al.
Publicado: (2021)

Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales
por: Sutton, AJ, et al.
Publicado: (2006)

Hepatitis C serosorting among people who inject drugs in rural Puerto Rico
por: Duncan, Ian, et al.
Publicado: (2017)

MBL2 and Hepatitis C Virus Infection among Injection Drug Users
por: Brown, Elizabeth E, et al.
Publicado: (2008)

Eradication of hepatitis C infection: The importance of targeting people who inject drugs
por: Hellard, Margaret, et al.
Publicado: (2014)

Hepatitis C Virus Dynamic Transmission Models Among People Who Inject Drugs
por: Woyesa, Shiferaw Bekele, et al.
Publicado: (2023)

Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients
por: Rossi, Carmine, et al.
Publicado: (2016)

Treatment, care and support for people co-infected with HIV and hepatitis C: a scoping review
por: Wilson, Michael G, et al.
Publicado: (2009)

Hepatitis C in injection drug users: It is time to treat
por: Grassi, Alberto, et al.
Publicado: (2017)

1050. Hepatitis C Infection amongst People who Inject Drugs (PWID): Injection Practices and Risk Factors
por: Sankar, Nityasri, et al.
Publicado: (2020)

Hepatitis C Infection and Treatment among Injecting Drug Users Attending General Practice: A Systematic Review and Meta-Analysis
por: Tandan, Meera, et al.
Publicado: (2023)

Occult hepatitis C infection identified in injection drug users with direct antiviral agents therapy and spontaneous resolution of hepatitis C virus infection
por: Silva, Eliane, et al.
Publicado: (2023)

Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
por: Higgs, Peter, et al.
Publicado: (2011)

HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan
por: Todd, Catherine S., et al.
Publicado: (2007)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Changes in alcohol use during hepatitis C treatment in persons who inject drugs
por: Martin, Madhuri, et al.
Publicado: (2022)

Global elimination of hepatitis C virus infection: Progresses and the remaining challenges
por: Taherkhani, Reza, et al.
Publicado: (2017)

Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment
por: Tsai, Wei-Chu, et al.
Publicado: (2023)

Acute hepatitis C virus infection: clinical update and remaining challenges
por: Liu, Chen-Hua, et al.
Publicado: (2023)

Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
por: Raad, Issam I, et al.
Publicado: (2018)

Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
por: Wang, Haiying, et al.
Publicado: (2018)

A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users
por: Wright, Nat MJ, et al.
Publicado: (2006)

HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar
por: Khatib, Ahmed, et al.
Publicado: (2017)

Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2021)

Prevalence and Seroincidence of Hepatitis B and Hepatitis C Infection in High Risk People Who Inject Drugs in China and Thailand
por: Jackson, J. Brooks, et al.
Publicado: (2014)

Therapeutic strategies and promising vaccine for hepatitis C virus infection
por: Adugna, Adane
Publicado: (2023)

Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response
por: Elsherif, Omar, et al.
Publicado: (2017)

Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection
por: Hsieh, Meng-Hsuan, et al.
Publicado: (2014)

Factors associated with HIV and hepatitis C infection among regular and non-regular injection drug users in Baltimore
por: Graham, CM, et al.
Publicado: (2006)

Hepatitis C Viremia Patterns in Incident Hepatitis C Infection and One Year Later in 150 Prospectively Tested Persons Who Inject Drugs
por: Alanko Blomé, Marianne, et al.
Publicado: (2014)

Hepatitis C Reinfection in People Who Inject Drugs in Resource-Limited Countries: A Systematic Review and Analysis
por: Muller, Abbe, et al.
Publicado: (2020)

Incidence of hepatitis C among people who inject drugs in Ireland
por: Carew, Anne Marie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_grbothtsf3c9h0c593uqb3hnju